샘플 요청 목록

 카트 문의
시장보고서
상품코드
1794621

세계의 수정체유화 기기 시장

Phacoemulsification Devices
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 278 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

수정체유화 기기 세계 시장은 2030년까지 27억 달러에 달할 전망

2024년에 21억 달러로 추정되는 수정체유화 기기 세계 시장은 분석 기간인 2024-2030년에 CAGR 4.3%로 성장하여 2030년에는 27억 달러에 달할 것으로 예측됩니다. 이 보고서에서 분석한 부문 중 하나인 수정체유화술용 소모품은 CAGR 5.1%를 기록하며 분석 기간 종료시에는 18억 달러에 달할 것으로 예측됩니다. 수정체유화술용 시스템 분야의 성장률은 분석 기간 동안 CAGR 2.8%로 추정됩니다.

미국 시장은 5억 8,170만 달러로 추정, 중국은 CAGR 8.0%로 성장 예측

미국의 수정체유화 기기 시장은 2024년에 5억 8,170만 달러로 추정됩니다. 세계 2위 경제 대국인 중국은 2024년부터 2030년까지 CAGR 8.0%로 성장하여 2030년에는 5억 6,840만 달러의 시장 규모에 달할 것으로 예측됩니다. 기타 주목할 만한 지역별 시장으로는 일본과 캐나다가 있고, 분석 기간 동안 CAGR은 각각 1.7%와 3.4%로 예측됩니다. 유럽에서는 독일이 CAGR 2.5%로 성장할 것으로 예측됩니다.

세계의 수정체유화 기기 시장 - 주요 동향과 촉진요인 정리

전 세계적으로 수정체유화 기기에 대한 수요가 증가하는 이유는 무엇일까?

특히 고령화 사회의 백내장 유병률 증가로 인해 수정체유화 기기에 대한 세계 수요가 꾸준히 급증하고 있습니다. 백내장은 전 세계적으로 시각장애와 실명의 주요 원인 중 하나이며, 백내장 수술은 최소침습적이고 회복이 빠르며 성공률이 높은 수정체유화술이 골드 스탠다드로 자리 잡고 있습니다. 특히 북미, 유럽, 아시아태평양 일부 지역에서는 노인 인구가 증가함에 따라 효율적이고 안전하며 신뢰할 수 있는 백내장 치료의 필요성이 증가하고 있습니다. 정부와 의료 시스템은 특히 예방 가능한 실명을 줄이는 것이 공중 보건의 의무인 국가에서 증가하는 환자 부담을 관리하기 위해 안과 의료 인프라에 많은 투자를 하고 있습니다. 또한, 환자들의 인식이 높아져 더 나은 수술 결과를 얻기 쉬워진 것이 기존의 낭외 백내장 절제술보다 수정체유화술이 빠르게 보급되는 데 기여하고 있습니다. 최신 수정체유화 시스템이 제공하는 편리함과 정확성은 신흥 시장의 가처분 소득 증가 및 의료 보험의 가용성 향상과 함께 이러한 첨단 기기의 보급을 더욱 촉진하고 있습니다. 또한, 자선 사업과 NGO 주도의 이니셔티브는 수정체유화술 기술을 소외된 지역에 도입하는 데 중요한 역할을 하고 있으며, 시장 저변을 확대하는 데 중요한 역할을 하고 있습니다. 이러한 시력 건강에 대한 관심의 증가는 전 세계적으로 삶의 질과 기능적 수명에 대한 관심이 높아지면서 더욱 가속화될 것으로 예상됩니다.

기술의 발전이 안과 수술의 정확성을 어떻게 재정의하고 있는가?

수정체유화 기기의 기술 혁신은 수술의 정확성, 안전성, 환자 결과를 획기적으로 개선하고 있습니다. 최신 기기에는 첨단 유체 시스템, 수술 중 실시간 피드백, 열 손상을 최소화하고 수정체 제거 효율을 향상시키는 에너지 조절 기능이 탑재되어 있습니다. 미세 절개 백내장 수술(MICS)로의 전환은 수술의 통제력을 떨어뜨리지 않으면서 더 작은 절개를 용이하게 하는 더 작고 정교한 핸드피스와 기계에 대한 수요를 창출하고 있습니다. 비틀림 초음파 기술, 지능형 흡입 제어, 통합형 광간섭 단층촬영기(OCT) 등의 기술 혁신은 백내장 수술 방법을 완전히 바꾸어 놓았습니다. 현재 많은 시스템이 렌즈의 경도, 환자의 눈의 해부학적 구조 및 외과 의사의 선호도에 따라 맞춤형 설정을 제공하여 합병증 감소와 함께 최적화된 결과를 제공합니다. 터치스크린 인터페이스와 클라우드 연결의 통합으로 실시간 데이터 추적 및 수술 결과 분석이 가능하여, 시술 교육 및 표준화가 모두 강화되었습니다. 또한, 펨토세컨드 레이저 보조 백내장 수술(FLACS)의 등장은 수정체 파쇄와 피막 절개 정확도를 향상시켜 유화흡입술을 보완하고 있습니다. 업계 기업들은 시스템의 인체공학적, 에너지 효율, 반응성을 높이기 위해 연구개발에 많은 투자를 하고 있습니다. 이러한 기술 혁신은 임상 결과를 개선할 뿐만 아니라, 더 많은 외과의사 집단에게 기기의 사용 편의성을 확대할 수 있습니다. 이 분야가 계속 발전함에 따라 첨단 수정체유화 시스템은 더욱 지능적이고 덜 침습적이며 개별 수술의 요구에 맞게 조정될 것입니다.

의료 인프라와 수술 교육이 시장 침투에 어떤 역할을 하는가?

수정체유화 기기의 보급과 채택은 숙련된 안과 의사의 유무와 의료 인프라의 충실도에 따라 크게 영향을 받습니다. 최첨단 수술 기기에 대한 접근성이 높은 고소득 국가에서는 백내장 제거술이 수정체유화술로 거의 완전히 대체되고 있습니다. 그러나 많은 중저소득 국가에서는 숙련된 외과의사 부족과 수술 센터 시설 부족으로 인해 수정체유화 기기를 본격적으로 도입하는 데 여전히 한계가 있습니다. 이러한 격차를 해소하기 위해 여러 제조업체와 비영리 단체가 전 세계 아웃리치 프로그램을 통해 교육 및 기술 향상 노력에 힘을 쏟고 있습니다. 체계적인 교육 모듈, 가상현실 시뮬레이터, 라이브 수술 워크샵은 새로운 세대의 안과 의사들이 수정체유화술 기술을 습득하는 데 도움이 되고 있습니다. 동시에 신흥국에서는 외래 수술 센터와 민간 안과 병원의 급증으로 인해 고품질의 비용 효율적인 수술 시스템에 대한 새로운 수요가 발생하고 있습니다. 백내장 수술을 포함한 보험 적용 및 정부 지원 의료 프로그램도 환자 수를 증가시켜 의료기관이 수정체유화 시스템에 대한 투자를 유도하고 있습니다. 또한, 수술 프로토콜과 인증 요건의 표준화로 인해 국제적인 치료 기준을 충족하기 위해 첨단 기기를 도입하는 병원이 증가하고 있습니다. 전 세계적으로 백내장으로 인한 실명률이 증가하고 있는 가운데, 이러한 기술을 널리 보급하기 위해서는 수술 능력과 임상의의 전문 지식의 확대가 필수적입니다. 의료 서비스 제공과 기술 개발에 대한 집중적인 투자로 인해 많은 미개척 시장이 빠르게 성장할 수 있는 여건이 조성되고 있습니다.

수정체유화 기기 시장을 이끄는 주요 성장 촉진요인은 무엇인가?

수정체유화 기기 시장의 성장은 기술 발전, 인구통계학적 변화, 의료 서비스 제공 모델의 진화와 관련된 몇 가지 요인에 의해 주도되고 있습니다. 주요 요인으로는 세계 인구의 급속한 고령화를 들 수 있으며, 이에 따라 노화에 따른 백내장 발병률이 높아지고, 이에 따라 수술의 필요성이 증가하고 있습니다. 이와 함께 개선된 유체역학, 실시간 수술 분석, 적응성 높은 에너지 공급 시스템 등 기기 기능의 지속적인 발전으로 수술 결과와 환자 안전이 크게 향상되었습니다. 최소침습적 시술과 정밀 기기에 대한 외과 의사들의 선호도가 높아지면서 수정체유화술이 백내장 제거술의 바람직한 방법으로 더욱 확고히 자리 잡고 있습니다. 의료 서비스 제공 측면에서는 개인 안과 클리닉, 외래 수술 센터, 안과 전문 네트워크의 확대로 인해 소형, 휴대성, 확장성이 뛰어난 수술 시스템에 대한 수요가 증가하고 있습니다. 소비자 행동도 중요한 역할을 하고 있으며, 환자들은 점점 더 빠른 회복, 고화질 시각적 결과, 레이저 지원을 통한 맞춤화를 요구하고 있습니다. 인도나 중국 같은 나라에서는 정부에서 자금을 지원하는 백내장 퇴치 프로그램이 있고, 유럽과 미국에서는 체계화된 상환 체계가 있기 때문에 이러한 선진적인 시스템에 재정적 실행 가능성과 접근성을 가져다 줍니다. 또한, 선택적 백내장 수술의 증가와 2차 의료센터 및 농촌 지역 의료센터로의 백내장 수술 확대는 기기 제조업체에게 새로운 길을 열어주고 있습니다. 마지막으로, 전 세계적으로 수술 교육 및 기기 규제의 조화로 인해 신기술의 시장 출시 시간이 단축되고, 경쟁력 있는 기술 혁신이 촉진되고, 지역 간 더 넓은 범위의 제품을 사용할 수 있게 되었습니다.

부문

제품(수정체유화술용 소모품, 수정체유화술용 시스템), 최종사용자(병원 최종사용자, 클리닉 최종사용자, 조사기관 최종사용자)

조사 대상 기업 사례

  • Alcon
  • Appasamy Associates
  • Bausch+Lomb
  • BEAVER-Visitec International
  • Carl Zeiss Meditec AG
  • D.O.R.C. Dutch Ophthalmic
  • Ellex Medical Lasers
  • Essilor Instruments
  • Geuder AG
  • Haag-Streit Group
  • Hoya Corporation
  • Johnson & Johnson Vision
  • LIGHTMED Corporation
  • LUMed
  • NIDEK Co., Ltd.
  • Optikon
  • Optos(a Nikon company)
  • Rumex International
  • STAAR Surgical
  • Topcon Corporation

AI 통합

Global Industry Analysts는 검증된 전문가 컨텐츠와 AI 툴을 통해 시장 정보와 경쟁 정보를 혁신하고 있습니다.

Global Industry Analysts는 일반적인 LLM 및 업계별 SLM 쿼리를 따르는 대신 비디오 기록, 블로그, 검색 엔진 조사, 방대한 양의 기업, 제품/서비스, 시장 데이터 등 세계 전문가로부터 수집한 컨텐츠 리포지토리를 구축했습니다.

관세 영향 계수

Global Industry Analysts는 본사 소재지, 제조거점, 수출입(완제품 및 OEM)을 기준으로 기업의 경쟁력 변화를 예측하고 있습니다. 이러한 복잡하고 다면적인 시장 역학은 매출원가(COGS) 증가, 수익성 하락, 공급망 재편 등 미시적, 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예상됩니다.

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트
  • 기타 중동
  • 아프리카

제4장 경쟁

KSM 25.08.28

Global Phacoemulsification Devices Market to Reach US$2.7 Billion by 2030

The global market for Phacoemulsification Devices estimated at US$2.1 Billion in the year 2024, is expected to reach US$2.7 Billion by 2030, growing at a CAGR of 4.3% over the analysis period 2024-2030. Phacoemulsification Consumables, one of the segments analyzed in the report, is expected to record a 5.1% CAGR and reach US$1.8 Billion by the end of the analysis period. Growth in the Phacoemulsification Systems segment is estimated at 2.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$581.7 Million While China is Forecast to Grow at 8.0% CAGR

The Phacoemulsification Devices market in the U.S. is estimated at US$581.7 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$568.4 Million by the year 2030 trailing a CAGR of 8.0% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.7% and 3.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.5% CAGR.

Global Phacoemulsification Devices Market - Key Trends & Drivers Summarized

Why Is the Demand for Phacoemulsification Devices Rising Across the Globe?

The global demand for phacoemulsification devices is witnessing a steady surge due to the rising prevalence of cataracts, particularly among the aging population. Cataracts remain one of the leading causes of visual impairment and blindness globally, and phacoemulsification has become the gold standard in cataract surgery due to its minimally invasive nature, faster recovery time, and high success rate. The increasing geriatric demographic, especially in regions like North America, Europe, and parts of Asia-Pacific, has driven the need for efficient, safe, and reliable cataract treatment options. Governments and healthcare systems are investing significantly in ophthalmic care infrastructure to manage the growing patient burden, particularly in countries with public health mandates to reduce preventable blindness. Moreover, increased patient awareness and the accessibility of better surgical outcomes are contributing to the rapid adoption of phacoemulsification over traditional extracapsular cataract extraction methods. The convenience and precision offered by modern phacoemulsification systems, combined with rising disposable incomes and greater availability of health insurance in emerging markets, have further encouraged the uptake of these advanced devices. Additionally, philanthropic and NGO-led initiatives are playing a significant role in bringing phacoemulsification technologies to underserved areas, broadening the market reach. This increased focus on visual health is expected to accelerate further with continued global emphasis on quality of life and functional longevity.

How Are Technological Advancements Redefining Surgical Precision in Ophthalmology?

Technological innovations in phacoemulsification devices are dramatically improving surgical precision, safety, and patient outcomes. Modern devices now come equipped with advanced fluidics systems, real-time intraoperative feedback, and enhanced energy modulation capabilities that minimize thermal damage and improve lens removal efficiency. The shift toward microincision cataract surgery (MICS) has created a demand for more compact and sophisticated handpieces and machines that facilitate smaller incisions without compromising surgical control. Innovations such as torsional ultrasound technology, intelligent aspiration control, and integrated optical coherence tomography (OCT) have transformed how cataract surgeries are performed. Many systems now offer customizable settings based on lens hardness, patient eye anatomy, and surgeon preferences, resulting in optimized outcomes with reduced complications. Integration of touchscreen interfaces and cloud connectivity allows real-time data tracking and surgical performance analysis, which enhances both procedural training and standardization. Furthermore, the rise of femtosecond laser-assisted cataract surgery (FLACS) is complementing phacoemulsification procedures by improving lens fragmentation and capsulotomy precision. Industry players are investing heavily in R&D to make systems more ergonomic, energy-efficient, and responsive. Such innovations not only boost clinical outcomes but also expand the usability of devices to newer surgeon cohorts. As the field continues to evolve, high-tech phacoemulsification systems are poised to become even more intelligent, less invasive, and tailored to individual surgical needs.

What Role Do Healthcare Infrastructure and Surgical Training Play in Market Penetration?

The spread and adoption of phacoemulsification devices are heavily influenced by the availability of skilled ophthalmic surgeons and the robustness of healthcare infrastructure. In high-income countries, where access to state-of-the-art surgical facilities is more common, phacoemulsification has almost entirely replaced older cataract extraction techniques. However, in many low- and middle-income nations, the lack of trained surgeons and under-equipped surgical centers continues to limit the full-scale adoption of phacoemulsification devices. To bridge this gap, several manufacturers and non-profit organizations are focusing on education and skill-building initiatives through global outreach programs. Structured training modules, virtual reality simulators, and live surgical workshops are helping to train a new generation of ophthalmologists in phacoemulsification techniques. At the same time, the proliferation of ambulatory surgical centers and private eye hospitals in emerging economies is creating new demand for high-quality, cost-effective surgical systems. Insurance coverage and government-sponsored health programs that include cataract surgery have also boosted patient volumes, prompting institutions to invest in phacoemulsification systems. Moreover, standardization of surgical protocols and accreditation requirements is encouraging more hospitals to adopt advanced equipment to meet international care benchmarks. As the global burden of cataract-related blindness grows, expanding surgical capacity and clinician expertise will be essential to enabling widespread adoption of these technologies. With targeted investment in healthcare delivery and skills development, many underpenetrated markets are poised for accelerated growth.

What Are the Key Growth Drivers Powering the Phacoemulsification Devices Market?

The growth in the phacoemulsification devices market is driven by several factors related to technological sophistication, changing demographics, and evolving healthcare delivery models. A primary driver is the rapid aging of the global population, which is leading to a higher incidence of age-related cataracts and consequently, a greater need for surgical intervention. In parallel, the continuous advancement of device functionality such as improved fluidics, real-time surgical analytics, and adaptive energy delivery systems has significantly elevated surgical outcomes and patient safety. Increasing surgeon preference for minimally invasive techniques and precision tools has further solidified phacoemulsification as the preferred method of cataract removal. On the healthcare delivery side, the expansion of private eye clinics, outpatient surgical centers, and specialized ophthalmology networks has amplified the demand for compact, portable, and scalable surgical systems. Consumer behavior is also playing a critical role, with patients increasingly seeking faster recovery, high-definition visual outcomes, and laser-assisted customization. Government-funded cataract elimination programs in countries like India and China, as well as structured reimbursement frameworks in Western nations, have provided financial viability and accessibility to these advanced systems. Additionally, the growing volume of elective cataract procedures and the expansion of cataract surgery into secondary and rural healthcare centers are opening new avenues for device manufacturers. Lastly, the global harmonization of surgical training and device regulation is accelerating time-to-market for new technologies, fueling competitive innovation and broader product availability across regions.

SCOPE OF STUDY:

The report analyzes the Phacoemulsification Devices market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Phacoemulsification Consumables, Phacoemulsification Systems); End-Use (Hospitals End-Use, Clinics End-Use, Research Institutes End-Use)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 44 Featured) -

  • Alcon
  • Appasamy Associates
  • Bausch + Lomb
  • BEAVER-Visitec International
  • Carl Zeiss Meditec AG
  • D.O.R.C. Dutch Ophthalmic
  • Ellex Medical Lasers
  • Essilor Instruments
  • Geuder AG
  • Haag-Streit Group
  • Hoya Corporation
  • Johnson & Johnson Vision
  • LIGHTMED Corporation
  • LUMed
  • NIDEK Co., Ltd.
  • Optikon
  • Optos (a Nikon company)
  • Rumex International
  • STAAR Surgical
  • Topcon Corporation

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Tariff Impact on Global Supply Chain Patterns
    • Phacoemulsification Devices - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Global Prevalence of Cataracts Propels Demand for Phacoemulsification Devices
    • Aging Population Trends Expand the Addressable Market for Minimally Invasive Eye Surgeries
    • Technological Advancements in Ultrasound Energy Delivery Drive Innovation in Phacoemulsification Systems
    • Improved Fluidics and Real-Time Feedback Mechanisms Strengthen the Business Case for Next-Gen Devices
    • Increased Surgical Volume in Emerging Markets Spurs Demand for Compact and Cost-Effective Systems
    • Shift Toward Day Surgery and Ambulatory Cataract Procedures Throws the Spotlight on Portable and Rapid-Cycle Devices
    • Rising Demand for Precision and Customization Drives Integration of Digital Imaging and AI-Enabled Platforms
    • Healthcare Infrastructure Expansion in Asia-Pacific and Latin America Fuels Equipment Procurement Growth
    • Preference for Single-Use Handpieces and Consumables Generates Recurring Revenue Streams
    • Surge in Demand for Premium Intraocular Lenses (IOLs) Supports Growth in Advanced Phaco Systems
    • Increased Focus on Surgical Safety and Efficiency Throws the Spotlight on Ergonomic and User-Centric Designs
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Phacoemulsification Devices Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Phacoemulsification Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Phacoemulsification Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 4: World 16-Year Perspective for Phacoemulsification Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Phacoemulsification Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Phacoemulsification Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 7: World 16-Year Perspective for Phacoemulsification Consumables by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Phacoemulsification Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Phacoemulsification Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 10: World 16-Year Perspective for Phacoemulsification Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 13: World 16-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 16: World 16-Year Perspective for Clinics End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Research Institutes End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Research Institutes End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 19: World 16-Year Perspective for Research Institutes End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Phacoemulsification Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 20: USA Recent Past, Current & Future Analysis for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 21: USA Historic Review for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 22: USA 16-Year Perspective for Phacoemulsification Devices by Product - Percentage Breakdown of Value Sales for Phacoemulsification Consumables and Phacoemulsification Systems for the Years 2014, 2025 & 2030
    • TABLE 23: USA Recent Past, Current & Future Analysis for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 25: USA 16-Year Perspective for Phacoemulsification Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Research Institutes End-Use for the Years 2014, 2025 & 2030
  • CANADA
    • TABLE 26: Canada Recent Past, Current & Future Analysis for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 27: Canada Historic Review for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 28: Canada 16-Year Perspective for Phacoemulsification Devices by Product - Percentage Breakdown of Value Sales for Phacoemulsification Consumables and Phacoemulsification Systems for the Years 2014, 2025 & 2030
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 31: Canada 16-Year Perspective for Phacoemulsification Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Research Institutes End-Use for the Years 2014, 2025 & 2030
  • JAPAN
    • Phacoemulsification Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 32: Japan Recent Past, Current & Future Analysis for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Japan Historic Review for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 34: Japan 16-Year Perspective for Phacoemulsification Devices by Product - Percentage Breakdown of Value Sales for Phacoemulsification Consumables and Phacoemulsification Systems for the Years 2014, 2025 & 2030
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 37: Japan 16-Year Perspective for Phacoemulsification Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Research Institutes End-Use for the Years 2014, 2025 & 2030
  • CHINA
    • Phacoemulsification Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 38: China Recent Past, Current & Future Analysis for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: China Historic Review for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 40: China 16-Year Perspective for Phacoemulsification Devices by Product - Percentage Breakdown of Value Sales for Phacoemulsification Consumables and Phacoemulsification Systems for the Years 2014, 2025 & 2030
    • TABLE 41: China Recent Past, Current & Future Analysis for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 43: China 16-Year Perspective for Phacoemulsification Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Research Institutes End-Use for the Years 2014, 2025 & 2030
  • EUROPE
    • Phacoemulsification Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 44: Europe Recent Past, Current & Future Analysis for Phacoemulsification Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 45: Europe Historic Review for Phacoemulsification Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 46: Europe 16-Year Perspective for Phacoemulsification Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 49: Europe 16-Year Perspective for Phacoemulsification Devices by Product - Percentage Breakdown of Value Sales for Phacoemulsification Consumables and Phacoemulsification Systems for the Years 2014, 2025 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Phacoemulsification Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Research Institutes End-Use for the Years 2014, 2025 & 2030
  • FRANCE
    • Phacoemulsification Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 53: France Recent Past, Current & Future Analysis for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: France Historic Review for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 55: France 16-Year Perspective for Phacoemulsification Devices by Product - Percentage Breakdown of Value Sales for Phacoemulsification Consumables and Phacoemulsification Systems for the Years 2014, 2025 & 2030
    • TABLE 56: France Recent Past, Current & Future Analysis for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 58: France 16-Year Perspective for Phacoemulsification Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Research Institutes End-Use for the Years 2014, 2025 & 2030
  • GERMANY
    • Phacoemulsification Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 59: Germany Recent Past, Current & Future Analysis for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Germany Historic Review for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 61: Germany 16-Year Perspective for Phacoemulsification Devices by Product - Percentage Breakdown of Value Sales for Phacoemulsification Consumables and Phacoemulsification Systems for the Years 2014, 2025 & 2030
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 64: Germany 16-Year Perspective for Phacoemulsification Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Research Institutes End-Use for the Years 2014, 2025 & 2030
  • ITALY
    • TABLE 65: Italy Recent Past, Current & Future Analysis for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Italy Historic Review for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 67: Italy 16-Year Perspective for Phacoemulsification Devices by Product - Percentage Breakdown of Value Sales for Phacoemulsification Consumables and Phacoemulsification Systems for the Years 2014, 2025 & 2030
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 70: Italy 16-Year Perspective for Phacoemulsification Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Research Institutes End-Use for the Years 2014, 2025 & 2030
  • UNITED KINGDOM
    • Phacoemulsification Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 71: UK Recent Past, Current & Future Analysis for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: UK Historic Review for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 73: UK 16-Year Perspective for Phacoemulsification Devices by Product - Percentage Breakdown of Value Sales for Phacoemulsification Consumables and Phacoemulsification Systems for the Years 2014, 2025 & 2030
    • TABLE 74: UK Recent Past, Current & Future Analysis for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 76: UK 16-Year Perspective for Phacoemulsification Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Research Institutes End-Use for the Years 2014, 2025 & 2030
  • SPAIN
    • TABLE 77: Spain Recent Past, Current & Future Analysis for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Spain Historic Review for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 79: Spain 16-Year Perspective for Phacoemulsification Devices by Product - Percentage Breakdown of Value Sales for Phacoemulsification Consumables and Phacoemulsification Systems for the Years 2014, 2025 & 2030
    • TABLE 80: Spain Recent Past, Current & Future Analysis for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Spain Historic Review for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 82: Spain 16-Year Perspective for Phacoemulsification Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Research Institutes End-Use for the Years 2014, 2025 & 2030
  • RUSSIA
    • TABLE 83: Russia Recent Past, Current & Future Analysis for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Russia Historic Review for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 85: Russia 16-Year Perspective for Phacoemulsification Devices by Product - Percentage Breakdown of Value Sales for Phacoemulsification Consumables and Phacoemulsification Systems for the Years 2014, 2025 & 2030
    • TABLE 86: Russia Recent Past, Current & Future Analysis for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Russia Historic Review for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 88: Russia 16-Year Perspective for Phacoemulsification Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Research Institutes End-Use for the Years 2014, 2025 & 2030
  • REST OF EUROPE
    • TABLE 89: Rest of Europe Recent Past, Current & Future Analysis for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Rest of Europe Historic Review for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 91: Rest of Europe 16-Year Perspective for Phacoemulsification Devices by Product - Percentage Breakdown of Value Sales for Phacoemulsification Consumables and Phacoemulsification Systems for the Years 2014, 2025 & 2030
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 94: Rest of Europe 16-Year Perspective for Phacoemulsification Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Research Institutes End-Use for the Years 2014, 2025 & 2030
  • ASIA-PACIFIC
    • Phacoemulsification Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 95: Asia-Pacific Recent Past, Current & Future Analysis for Phacoemulsification Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 96: Asia-Pacific Historic Review for Phacoemulsification Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 97: Asia-Pacific 16-Year Perspective for Phacoemulsification Devices by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 100: Asia-Pacific 16-Year Perspective for Phacoemulsification Devices by Product - Percentage Breakdown of Value Sales for Phacoemulsification Consumables and Phacoemulsification Systems for the Years 2014, 2025 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 16-Year Perspective for Phacoemulsification Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Research Institutes End-Use for the Years 2014, 2025 & 2030
  • AUSTRALIA
    • Phacoemulsification Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 104: Australia Recent Past, Current & Future Analysis for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Australia Historic Review for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 106: Australia 16-Year Perspective for Phacoemulsification Devices by Product - Percentage Breakdown of Value Sales for Phacoemulsification Consumables and Phacoemulsification Systems for the Years 2014, 2025 & 2030
    • TABLE 107: Australia Recent Past, Current & Future Analysis for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Australia Historic Review for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 109: Australia 16-Year Perspective for Phacoemulsification Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Research Institutes End-Use for the Years 2014, 2025 & 2030
  • INDIA
    • Phacoemulsification Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 110: India Recent Past, Current & Future Analysis for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: India Historic Review for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 112: India 16-Year Perspective for Phacoemulsification Devices by Product - Percentage Breakdown of Value Sales for Phacoemulsification Consumables and Phacoemulsification Systems for the Years 2014, 2025 & 2030
    • TABLE 113: India Recent Past, Current & Future Analysis for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: India Historic Review for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 115: India 16-Year Perspective for Phacoemulsification Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Research Institutes End-Use for the Years 2014, 2025 & 2030
  • SOUTH KOREA
    • TABLE 116: South Korea Recent Past, Current & Future Analysis for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: South Korea Historic Review for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 118: South Korea 16-Year Perspective for Phacoemulsification Devices by Product - Percentage Breakdown of Value Sales for Phacoemulsification Consumables and Phacoemulsification Systems for the Years 2014, 2025 & 2030
    • TABLE 119: South Korea Recent Past, Current & Future Analysis for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: South Korea Historic Review for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 121: South Korea 16-Year Perspective for Phacoemulsification Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Research Institutes End-Use for the Years 2014, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 122: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Rest of Asia-Pacific Historic Review for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 124: Rest of Asia-Pacific 16-Year Perspective for Phacoemulsification Devices by Product - Percentage Breakdown of Value Sales for Phacoemulsification Consumables and Phacoemulsification Systems for the Years 2014, 2025 & 2030
    • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Rest of Asia-Pacific Historic Review for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 16-Year Perspective for Phacoemulsification Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Research Institutes End-Use for the Years 2014, 2025 & 2030
  • LATIN AMERICA
    • Phacoemulsification Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 128: Latin America Recent Past, Current & Future Analysis for Phacoemulsification Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 129: Latin America Historic Review for Phacoemulsification Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 130: Latin America 16-Year Perspective for Phacoemulsification Devices by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 133: Latin America 16-Year Perspective for Phacoemulsification Devices by Product - Percentage Breakdown of Value Sales for Phacoemulsification Consumables and Phacoemulsification Systems for the Years 2014, 2025 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 136: Latin America 16-Year Perspective for Phacoemulsification Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Research Institutes End-Use for the Years 2014, 2025 & 2030
  • ARGENTINA
    • TABLE 137: Argentina Recent Past, Current & Future Analysis for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Argentina Historic Review for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 139: Argentina 16-Year Perspective for Phacoemulsification Devices by Product - Percentage Breakdown of Value Sales for Phacoemulsification Consumables and Phacoemulsification Systems for the Years 2014, 2025 & 2030
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Argentina Historic Review for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 142: Argentina 16-Year Perspective for Phacoemulsification Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Research Institutes End-Use for the Years 2014, 2025 & 2030
  • BRAZIL
    • TABLE 143: Brazil Recent Past, Current & Future Analysis for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Brazil Historic Review for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 145: Brazil 16-Year Perspective for Phacoemulsification Devices by Product - Percentage Breakdown of Value Sales for Phacoemulsification Consumables and Phacoemulsification Systems for the Years 2014, 2025 & 2030
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Brazil Historic Review for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 148: Brazil 16-Year Perspective for Phacoemulsification Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Research Institutes End-Use for the Years 2014, 2025 & 2030
  • MEXICO
    • TABLE 149: Mexico Recent Past, Current & Future Analysis for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Mexico Historic Review for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 151: Mexico 16-Year Perspective for Phacoemulsification Devices by Product - Percentage Breakdown of Value Sales for Phacoemulsification Consumables and Phacoemulsification Systems for the Years 2014, 2025 & 2030
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Mexico Historic Review for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 154: Mexico 16-Year Perspective for Phacoemulsification Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Research Institutes End-Use for the Years 2014, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 155: Rest of Latin America Recent Past, Current & Future Analysis for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Rest of Latin America Historic Review for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 157: Rest of Latin America 16-Year Perspective for Phacoemulsification Devices by Product - Percentage Breakdown of Value Sales for Phacoemulsification Consumables and Phacoemulsification Systems for the Years 2014, 2025 & 2030
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America Historic Review for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 160: Rest of Latin America 16-Year Perspective for Phacoemulsification Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Research Institutes End-Use for the Years 2014, 2025 & 2030
  • MIDDLE EAST
    • Phacoemulsification Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 161: Middle East Recent Past, Current & Future Analysis for Phacoemulsification Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 162: Middle East Historic Review for Phacoemulsification Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 163: Middle East 16-Year Perspective for Phacoemulsification Devices by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 166: Middle East 16-Year Perspective for Phacoemulsification Devices by Product - Percentage Breakdown of Value Sales for Phacoemulsification Consumables and Phacoemulsification Systems for the Years 2014, 2025 & 2030
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 169: Middle East 16-Year Perspective for Phacoemulsification Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Research Institutes End-Use for the Years 2014, 2025 & 2030
  • IRAN
    • TABLE 170: Iran Recent Past, Current & Future Analysis for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Iran Historic Review for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 172: Iran 16-Year Perspective for Phacoemulsification Devices by Product - Percentage Breakdown of Value Sales for Phacoemulsification Consumables and Phacoemulsification Systems for the Years 2014, 2025 & 2030
    • TABLE 173: Iran Recent Past, Current & Future Analysis for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Iran Historic Review for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 175: Iran 16-Year Perspective for Phacoemulsification Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Research Institutes End-Use for the Years 2014, 2025 & 2030
  • ISRAEL
    • TABLE 176: Israel Recent Past, Current & Future Analysis for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Israel Historic Review for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 178: Israel 16-Year Perspective for Phacoemulsification Devices by Product - Percentage Breakdown of Value Sales for Phacoemulsification Consumables and Phacoemulsification Systems for the Years 2014, 2025 & 2030
    • TABLE 179: Israel Recent Past, Current & Future Analysis for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Israel Historic Review for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 181: Israel 16-Year Perspective for Phacoemulsification Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Research Institutes End-Use for the Years 2014, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 182: Saudi Arabia Recent Past, Current & Future Analysis for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Saudi Arabia Historic Review for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 184: Saudi Arabia 16-Year Perspective for Phacoemulsification Devices by Product - Percentage Breakdown of Value Sales for Phacoemulsification Consumables and Phacoemulsification Systems for the Years 2014, 2025 & 2030
    • TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Saudi Arabia Historic Review for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 187: Saudi Arabia 16-Year Perspective for Phacoemulsification Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Research Institutes End-Use for the Years 2014, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 188: UAE Recent Past, Current & Future Analysis for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: UAE Historic Review for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 190: UAE 16-Year Perspective for Phacoemulsification Devices by Product - Percentage Breakdown of Value Sales for Phacoemulsification Consumables and Phacoemulsification Systems for the Years 2014, 2025 & 2030
    • TABLE 191: UAE Recent Past, Current & Future Analysis for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: UAE Historic Review for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 193: UAE 16-Year Perspective for Phacoemulsification Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Research Institutes End-Use for the Years 2014, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 194: Rest of Middle East Recent Past, Current & Future Analysis for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Rest of Middle East Historic Review for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 196: Rest of Middle East 16-Year Perspective for Phacoemulsification Devices by Product - Percentage Breakdown of Value Sales for Phacoemulsification Consumables and Phacoemulsification Systems for the Years 2014, 2025 & 2030
    • TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Rest of Middle East Historic Review for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 199: Rest of Middle East 16-Year Perspective for Phacoemulsification Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Research Institutes End-Use for the Years 2014, 2025 & 2030
  • AFRICA
    • Phacoemulsification Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 200: Africa Recent Past, Current & Future Analysis for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Africa Historic Review for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 202: Africa 16-Year Perspective for Phacoemulsification Devices by Product - Percentage Breakdown of Value Sales for Phacoemulsification Consumables and Phacoemulsification Systems for the Years 2014, 2025 & 2030
    • TABLE 203: Africa Recent Past, Current & Future Analysis for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Africa Historic Review for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 205: Africa 16-Year Perspective for Phacoemulsification Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Research Institutes End-Use for the Years 2014, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제